🇺🇸 FDA
Patent

US 7153509

Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope

granted A61KA61K2039/57A61K39/00

Quick answer

US patent 7153509 (Immunogenic peptides comprising a T-helper epitope and a B-cell neutralizing antibody epitope) held by The Regents of the University of California expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/57, A61K39/00, A61P, A61P31/18